A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
Conditions:   Non-small Cell Lung Cancer;   Metastatic Non Small Cell Lung Cancer;   Nsclc;   NSCLC Stage IV;   Minimal Residual Disease;   Non Small Cell Lung Cancer Metastatic
Interventions:   Procedure: Local ablative therapy;   Other: Blood collection to assess for ctDNA
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 24, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments